Genome Insight
Providing a comprehensive view of a patient's entire genetic profile through WGS analysis and interpretations.
Launch date
Employees
Market cap
-
Enterprise valuation
€105m (Public information from Nov 2023)
Company register number 2958801643
Daejeon South Korea (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
* | N/A | $400k | Seed |
* | $6.0m | Series A | |
* | $23.0m | Series B | |
* | N/A | $4.5m Valuation: $115m | Late VC |
* | $23.0m Valuation: $115m | Series B | |
Total Funding | €51.7m |
Related Content
Recent News about Genome Insight
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.